Deletion of gp130 in myeloid cells modulates IL-6-release and is associated with more severe liver injury of Con A hepatitis

European Journal of Cell Biology

Volumn 91, Issue 6-7, 2012, Pages 576-581

  Lutz, H H ^a   Sackett, S D ^a   Kroy, D C ^a,b   Gassler, N ^a   Trautwein, C ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Concanavalin A; Gp130; Hepatitis; IL 6; LysMCre; Macrophages

Indexed keywords

ALANINE AMINOTRANSFERASE; CD11B ANTIGEN; CONCANAVALIN A; GLYCOPROTEIN GP 130; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; THIOGLYCOLIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION REGULATION; HEPATITIS; HISTOPATHOLOGY; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LIVER INJURY; LIVER NECROSIS; MACROPHAGE; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CONCANAVALIN A; CYTOKINE RECEPTOR GP130; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID CELLS;

ANIMALIA;

EID: 84860260890     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2011.09.006     Document Type: Article

References (18)

1. Bode J.G., Nimmesgern A., Schmitz J., Schaper F., Schmitt M., Frisch W., Haussinger D., Heinrich P.C., Graeve L. LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett. 1999, 463:365-370.
2. Clausen B.E., Burkhardt C., Reith W., Renkawitz R., Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999, 8:265-277.
3. Dienes H.P., Drebber U. Pathology of immune-mediated liver injury. Dig. Dis. 2010, 28:57-62.
4. Gantner F., Leist M., Kusters S., Vogt K., Volk H.D., Tiegs G. T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp. Cell Res. 1996, 229:137-146.
5. Hernandez-Gea V., Friedman S.L. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. 2011, 6:425-456.
6. Hirohashi N., Morrison D.C. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect. Immun. 1996, 64:1011-1015.
7. Klein C., Wustefeld T., Assmus U., Roskams T., Rose-John S., Muller M., Manns M.P., Ernst M., Trautwein C. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J. Clin. Invest. 2005, 115:860-869.
8. Luedde T., Assmus U., Wustefeld T., Meyer zu Vilsendorf A., Roskams T., Schmidt-Supprian M., Rajewsky K., Brenner D.A., Manns M.P., Pasparakis M., Trautwein C. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J. Clin. Invest. 2005, 115:849-859.
9. Sakamori R., Takehara T., Ohnishi C., Tatsumi T., Ohkawa K., Takeda K., Akira S., Hayashi N. Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice. Hepatology 2007, 46:1564-1573.
10. Sander L.E., Obermeier F., Dierssen U., Kroy D.C., Singh A.K., Seidler U., Streetz K.L., Lutz H.H., Muller W., Tacke F., Trautwein C. Gp130 signaling promotes development of acute experimental colitis by facilitating early neutrophil/macrophage recruitment and activation. J. Immunol. 2008, 181:3586-3594.
11. Sodenkamp J., Behrends J., Forster I., Muller W., Ehlers S., Holscher C. gp130 on macrophages/granulocytes modulates inflammation during experimental tuberculosis. Eur. J. Cell Biol. 2011, 90:505-514.
12. Streetz K.L., Tacke F., Leifeld L., Wustefeld T., Graw A., Klein C., Kamino K., Spengler U., Kreipe H., Kubicka S., Muller W., Manns M.P., Trautwein C. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases. Hepatology 2003, 38:218-229.
13. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49.
14. Tiegs G. Experimental hepatitis and role of cytokines. Acta Gastroenterol. Belg. 1997, 60:176-179.
15. Tiegs G., Hentschel J., Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 1992, 90:196-203.
16. Trautwein C., Rakemann T., Brenner D.A., Streetz K., Licato L., Manns M.P., Tiegs G. Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 1998, 114:1035-1045.
17. Yang J., Liao X., Agarwal M.K., Barnes L., Auron P.E., Stark G.R. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 2007, 21:1396-1408.
18. Yasukawa H., Ohishi M., Mori H., Murakami M., Chinen T., Aki D., Hanada T., Takeda K., Akira S., Hoshijima M., Hirano T., Chien K.R., Yoshimura A. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 2003, 4:551-556.